SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-006976
Filing Date
2024-01-26
Accepted
2024-01-26 07:13:27
Documents
12
Period of Report
2024-01-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244107d3_8k.htm   iXBRL 8-K 33383
  Complete submission text file 0001104659-24-006976.txt   207559

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA apre-20240126.xsd EX-101.SCH 3006
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE apre-20240126_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apre-20240126_pre.xml EX-101.PRE 22353
6 EXTRACTED XBRL INSTANCE DOCUMENT tm244107d3_8k_htm.xml XML 3316
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 24564122
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)